[
  {
    "title": "Is Sanofi (ENXTPA:SAN) Offering An Opportunity After A 19.5% One Year Share Price Fall",
    "link": "https://finance.yahoo.com/news/sanofi-enxtpa-san-offering-opportunity-151203918.html",
    "publisher": "Simply Wall St.",
    "date": "2026-02-27T15:12:03Z",
    "type": "STORY"
  },
  {
    "title": "Sanofi Says Acoziborole Winthrop for Sleeping Sickness Received Positive CHMP Opinion",
    "link": "https://finance.yahoo.com/news/sanofi-says-acoziborole-winthrop-sleeping-120904530.html",
    "publisher": "MT Newswires",
    "date": "2026-02-27T12:09:04Z",
    "type": "STORY"
  },
  {
    "title": "Novavax Q4 Earnings Call Highlights",
    "link": "https://www.marketbeat.com/instant-alerts/novavax-q4-earnings-call-highlights-2026-02-26/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "publisher": "MarketBeat",
    "date": "2026-02-27T05:07:26Z",
    "type": "STORY"
  },
  {
    "title": "Teva And Sanofi Data Add Potential Branded Growth Option In IBD",
    "link": "https://finance.yahoo.com/news/teva-sanofi-data-add-potential-021047645.html",
    "publisher": "Simply Wall St.",
    "date": "2026-02-27T02:10:47Z",
    "type": "STORY"
  },
  {
    "title": "Recursion Pharmaceuticals Inc (RXRX) Q4 2025 Earnings Call Highlights: Strategic Milestones and ...",
    "link": "https://finance.yahoo.com/news/recursion-pharmaceuticals-inc-rxrx-q4-010030630.html",
    "publisher": "GuruFocus.com",
    "date": "2026-02-27T01:00:30Z",
    "type": "STORY"
  },
  {
    "title": "Kymera Therapeutics Q4 Earnings Call Highlights",
    "link": "https://www.marketbeat.com/instant-alerts/kymera-therapeutics-q4-earnings-call-highlights-2026-02-26/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "publisher": "MarketBeat",
    "date": "2026-02-26T22:03:35Z",
    "type": "STORY"
  },
  {
    "title": "Sanofiâ€™s Dupixent Win And New CEO Focus Attention On Execution",
    "link": "https://finance.yahoo.com/news/sanofi-dupixent-win-ceo-focus-211146210.html",
    "publisher": "Simply Wall St.",
    "date": "2026-02-26T21:11:46Z",
    "type": "STORY"
  },
  {
    "title": "Novavax Inc (NVAX) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ...",
    "link": "https://finance.yahoo.com/news/novavax-inc-nvax-q4-2025-211144949.html",
    "publisher": "GuruFocus.com",
    "date": "2026-02-26T21:11:44Z",
    "type": "STORY"
  },
  {
    "title": "Kymera Therapeutics Inc (KYMR) Q4 2025 Earnings Call Highlights: Strategic Collaborations and ...",
    "link": "https://finance.yahoo.com/news/kymera-therapeutics-inc-kymr-q4-210806265.html",
    "publisher": "GuruFocus.com",
    "date": "2026-02-26T21:08:06Z",
    "type": "STORY"
  },
  {
    "title": "Recursion Pharmaceuticals (RXRX) Hits Clinical Milestones as 2025 Revenue Grows to $74.7M",
    "link": "https://finance.yahoo.com/news/recursion-pharmaceuticals-rxrx-hits-clinical-192714543.html",
    "publisher": "Insider Monkey",
    "date": "2026-02-26T19:27:14Z",
    "type": "STORY"
  }
]